Product Name: VIP (Vasoactive Intestinal Peptide) (Aqueous Solution) Chemical Information:

• Molecular Formula: C₁₄₇H₂₃₈N₄₄O₄₂S
• Molecular Weight: ~3,326 g/mol
• Sequence: His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH₂
• Structure Class: Synthetic 28 amino acid peptide (glucagon/secretin-related peptide)

Molecular Structure:   Product Description: Vasoactive Intestinal Peptide (VIP) is a 28-amino-acid synthetic peptide belonging to the glucagon/secretin peptide superfamily. It is structurally characterized by a defined linear amino acid sequence and is produced via controlled peptide synthesis for use in laboratory research environments. In research settings, VIP is utilized in analytical and experimental systems to examine peptide structure, stability, and physicochemical properties under controlled conditions. This product is supplied as a pre-formulated aqueous research solution, designed to provide consistency and stability for controlled research applications. VIP is intended exclusively for in vitro use by qualified research professionals. Research Applications:

• Analytical evaluation of peptide structure and sequence characteristics
• Examination of peptide stability and degradation profiles under controlled conditions
• Investigation of peptide–receptor binding interactions in isolated assay systems
• Characterization of peptide behavior in biochemical and cell-based experimental models

Storage and Handling:

• For optimal stability, store sealed product in a cool, dark, and dry environment. Refrigeration at 2–8 °C is recommended after first puncture or once the seal has been compromised
• Do not freeze
• Protect from light
• Maintain sterile handling practices during research use

Product Specifications:

• Bottle Volume: 15 mL
• Total Content: 20 mg per bottle
• Dispenses per Container: ~100
• Per Dispense: ~200 mcg
• Analytical Approach to Finished Formulations: Purity is a metric used for isolated raw materials, such as lyophilized peptide powders. Finished formulations—such as capsules, liquids, and topicals—contain multiple components, including excipients and stabilizers. In these systems, a single purity value does not accurately represent the overall composition. Instead, identity and assay (content) are reported on the COA to confirm the presence of the correct compound and to verify that the labeled amount per unit is accurate. This approach reflects standard analytical practice and provides more meaningful information for research applications.

Compliance Notice: VIP (Vasoactive Intestinal Peptide) (Aqueous Solution) is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse of this product is strictly prohibited and may violate federal, state, or local laws. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.